Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study

Possible Reduction of Cardiac Risk after Supplementation with Epigallocatechin Gallate and Increase of Ketone Bodies in the Blood in Patients with Multiple Sclerosis. A Pilot Study

Multiple sclerosis (MS) is a neurodegenerative disease that causes anthropometric changes characterised by functional disability, increase in fat mass, and decrease in lean mass. All these variables are related to a greater cardiac risk. The polyphenol epigallocatechin gallate (EGCG) and an increase...

Full description

Bibliographic Details
Main Authors: Benlloch, María, Cuerda Ballester, María, Drehmer, Eraci, Platero, Jose Luis, Carrera Juliá, Sandra, López Rodríguez, María Mar, Ceron, Jose Joaquin, Tvarijonaviciute, Asta, Navarro, Marí Ángeles, Moreno, Mari Luz, Rubia Ortí, Jose Enrique de la
Format: info:eu-repo/semantics/article
Language:English
Published: MDPI 2020
Subjects:
multiple sclerosis
cardiac risk
epigallocatechin gallate
ketone bodies
Online Access:http://hdl.handle.net/10835/9172

Internet

http://hdl.handle.net/10835/9172

Similar Items